Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200563 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Samantha Gokhale und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ. Hauptthemen laut MEDLINE: B-Lymphocytes, Immunoglobulin Class Switching, Interleukin-4, Receptors, Interleukin-9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | NCI | Basic Research Laboratory.
Abstract (Originalsprache)
The pleiotropic cytokine IL-9 signals to target cells by binding to a heterodimeric receptor consisting of the unique subunit IL-9R and the common subunit γ-chain shared by multiple cytokines of the γ-chain family. In the current study, we found that the expression of IL-9R was strikingly upregulated in mouse naive follicular B cells genetically deficient in TNFR-associated factor 3 (TRAF3), a critical regulator of B cell survival and function. The highly upregulated IL-9R on Traf3−/− follicular B cells conferred responsiveness to IL-9, including IgM production and STAT3 phosphorylation. Interestingly, IL-9 significantly enhanced class switch recombination to IgG1 induced by BCR crosslinking plus IL-4 in Traf3−/− B cells, which was not observed in littermate control B cells. We further demonstrated that blocking the JAK-STAT3 signaling pathway abrogated the enhancing effect of IL-9 on class switch recombination to IgG1 induced by BCR crosslinking plus IL-4 in Traf3−/− B cells. Our study thus revealed, to our knowledge, a novel pathway that TRAF3 suppresses B cell activation and Ig isotype switching by inhibiting IL-9R-JAK-STAT3 signaling. Taken together, our findings provide (to our knowledge) new insights into the TRAF3-IL-9R axis in B cell function and have significant implications for the understanding and treatment of a variety of human diseases involving aberrant B cell activation such as autoimmune disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ.
- Graduate Program in Cellular and Molecular Pharmacology, Rutgers University, Piscataway, NJ.
- Division of Molecular Biology, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Japan.
- Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
ORCID-Profile: Samantha Gokhale, Jemmie Tsai, Brygida Matracz, Shogo Takatsuka, Jaeyong Jung, Ping Xie
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- HHS | NIH | NCI | Basic Research Laboratory
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- DOD | USA | MEDCOM | CDMRP | DOD Peer Reviewed Cancer Research Program
Zitieren
APA
Gokhale, S., Victor, E., Tsai, J., Spirollari, E., Matracz, B., Takatsuka, S., Jung, J., Kitamura, D., & Xie, P. (2023). Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200563
Vancouver
Gokhale S, Victor E, Tsai J, Spirollari E, Matracz B, Takatsuka S, et al. Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200563
BibTeX
@article{Gokhale2023,
author = {Gokhale, Samantha and Victor, Eton and Tsai, Jemmie and Spirollari, Eris and Matracz, Brygida and Takatsuka, Shogo and Jung, Jaeyong and Kitamura, Daisuke and Xie, Ping},
title = {Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200563}
}
EUVIMED